AMO Pharma is a biopharmaceutical company incorporated in February of 2015. The co-founder, Dr. Michael Snape, has extensive experience in senior scientific and operational roles in both large pharma and biotech companies spanning more than twenty-five years, and has brought together a targeted and experienced senior management team with a proven track record of success in all phases of product development and acquisition. The company is working to identify and advance promising therapies for the treatment of serious and debilitating diseases in patient populations with significant areas of unmet need, including rare, debilitating childhood onset neurogenetic disorders with limited or no treatment options. AMO-02 is an investigational medicine that has not yet been approved for the treatment of patients anywhere in the world. For more information, please visit the AMO Pharma website at http://www.amo-pharma.com/.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2015
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was AMO Pharma LTD founded?
AMO Pharma LTD was founded in 2015.
What industry is AMO Pharma LTD in?
AMO Pharma LTD operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is AMO Pharma LTD based?
AMO Pharma LTD is headquartered in Durham, United States.
Find investors for your startup like AMO Pharma LTD
Gritt sends AI-personalised outreach to each investor — from your Gmail
